Yuan Tian
Net worth: - $ as of 2026-08-30
Net worth: - $ as of 2026-08-30
Yuan Tian is currently the Chairman and Chief Executive Officer at CIFCO International Group since 2007.
Prior to this, he was the Chairman at China International Futures Co., Ltd. He also served as a Non-Executive Director at Quam Plus International Financial Ltd. from 2006 to 2008.
Additionally, he was a Director at ContraFect Corp.
and a Non-Executive Director at Ascentage Pharma Group International Co., Ltd. Dr. Tian holds a doctorate degree from Wuhan University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-12-30 | 0 ( -.--% ) | - $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
CIFCO International Group
CIFCO International Group Investment ManagersFinance Provides financial advisory services | Chief Executive Officer | 2006-12-31 |
| Companies | Position | End |
|---|---|---|
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Director/Board Member | 2022-05-19 |
| QUAM PLUS INTERNATIONAL FINANCIAL LIMITED | Director/Board Member | 2008-09-10 |
| CONTRAFECT CORPORATION | Director/Board Member | - |
China International Futures Co., Ltd.
China International Futures Co., Ltd. Investment Banks/BrokersFinance Provides commodities trading services | Chairman | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Quam Plus International Financial Ltd.
Quam Plus International Financial Ltd. Investment Banks/BrokersFinance Provides securities brokerage, financial advisory, and fund management services | Finance |
Wuhan University
Wuhan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
China International Futures Co., Ltd.
China International Futures Co., Ltd. Investment Banks/BrokersFinance Provides commodities trading services | Finance |
ContraFect Corp.
ContraFect Corp. BiotechnologyHealth Technology Engages in discovery and development of direct lytic agents for life-threatening & drug-resistant infectious diseases | Health Technology |
CIFCO International Group
CIFCO International Group Investment ManagersFinance Provides financial advisory services | Finance |
Ascentage Pharma Group International Co., Ltd.
Ascentage Pharma Group International Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering, developing and commercializing of therapies for hematological malignancies | Health Technology |
Select your edition
All financial news and data tailored to specific country editions